Literature DB >> 22303773

Doctors in court, honour, and professional ethics: two scandals in Imperial Germany.

Andreas-Holger Maehle1.   

Abstract

Comparing two public medical affairs which involved disciplinary proceedings and libel actions, one from Bavaria and one from Prussia, this article analyzes the dynamics behind legal conflicts over doctors' professional ethics in Imperial Germany. In both the case of Dr Maurice Hutzler, who committed suicide after conflicts with senior colleagues at the Gisela Children's Hospital and a sentence of the court of honour of the Munich Medical District Society, and the Berlin "patient trade" affair, in which the medical professors Ernst von Leyden, Hermann Senator, Karl Anton Ewald and Carl Posner were accused of having made payments to middlemen for bringing them lucrative private patients, notions of personal and professional honour played a central role. The Munich case highlighted shortcomings of the Bavarian medical court of honour system, which was less developed than its Prussian counterpart. The analysis of the two cases suggests that the ethics of medical practice in early twentieth-century Germany should be viewed as part of a culture of honour.

Entities:  

Mesh:

Year:  2011        PMID: 22303773      PMCID: PMC3696867     

Source DB:  PubMed          Journal:  Gesnerus        ISSN: 0016-9161


  3 in total

1.  Professional ethics and discipline: the Prussian medical courts of honour, 1899-1920.

Authors:  A H Maehle
Journal:  Medizinhist J       Date:  1999

2.  'Patient trade' in Germany: an ethical issue at the practitioner--clinician interface in 1909 and 2009.

Authors:  Andreas-Holger Maehle
Journal:  Med Humanit       Date:  2010-11-15

3.  Honor codes and medical ethics in modern France.

Authors:  R A Nye
Journal:  Bull Hist Med       Date:  1995       Impact factor: 1.314

  3 in total
  1 in total

1.  'God's ethicist': Albert Moll and his medical ethics in theory and practice.

Authors:  Andreas-Holger Maehle
Journal:  Med Hist       Date:  2012-04       Impact factor: 1.419

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.